| Literature DB >> 24326198 |
Chung How Kau1, Alpdogan Kantarci, Tim Shaughnessy, Amornpong Vachiramon, Peerapong Santiwong, Alvaro de la Fuente, Darya Skrenes, Dennis Ma, Peter Brawn.
Abstract
BACKGROUND: Numerous strategies have been proposed to decrease the treatment time a patient requires in orthodontic treatment. Recently, a number of device-accelerated therapies have emerged in orthodontics. Photobiomodulation is an emerging area of science that has clinical applications in a number of human biological processes. The aim of this study was to determine if photobiomodulation reduces the treatment time in the alignment phase of orthodontic treatment.Entities:
Mesh:
Year: 2013 PMID: 24326198 PMCID: PMC4384947 DOI: 10.1186/2196-1042-14-30
Source DB: PubMed Journal: Prog Orthod ISSN: 1723-7785 Impact factor: 2.750
Demographics of the patient population
| Number | Gender | Age (years) | |||
|---|---|---|---|---|---|
| %female | Mean | SD | Range | ||
| Center | |||||
| 1 | 26 | 77 | 23 | 6 | 13 to 35 |
| 2 | 20 | 50 | 14 | 3 | 11 to 27 |
| 3 | 12 | 52 | 14 | 2 | 11 to 18 |
| 4 | 32 | 75 | 17 | 7 | 10 to 36 |
| Total | 90 | 69 | 18 | 7 | 10 to 36 |
Figure 1Device components and a clinical presentation. (A, B) A set of four extra-oral treatment arrays, each with a flexible printed circuit board and a set of LEDs mounted on a contoured heat sink and infrared-transmissible plastic lens, with conductive cables to the controller. (C) A headset similar to an eyeglass support structure to be worn by the patient on a daily or weekly basis, with attachment and adjustment mechanisms to position the treatment arrays in the appropriate location for the given patient. (D, E, F) Clinical presentation of the device.
Treatment outcome descriptive statistics comparing control to treatment group
| Arches | Time intervals | Initial LII (mm) | Alignment rate (mm/week) | ||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Number | Sample | Maxilla/mandible | Sample | Maxilla/mandible | Mean | SD | Median | Range | Mean | SD | Median | Range | |
| Control | 17 | 23 | 13/10 | 52 | 32/20 | 5.04 | 3.34 | 4.24 | 1.2 to 15.3 | 0.49 | 0.40 | 0.45 | -0.15 to 1.55 |
| Test | 73 | 113 | 59/54 | 262 | 140/122 | 6.35 | 3.87 | 5.55 | 1.1 to 15.3 | 1.12 | 1.05 | 0.84 | -0.19 to 7.49 |
|
| 0.04 | <0.00001 | |||||||||||
Figure 2A representative case treated with conventional orthodontic method in the control group. (A) Baseline (day 0); LII is 3.80 mm. (B) Day 42; LII is 2.20 mm. (C) Day 119; LII is 1.70 mm. (D) Day 161; LII is 0.50 mm.
Figure 3A representative case treated with LAO method in the test group. (A) Baseline (day 0); LII is 12.16 mm. (B) Day 14; LII is 9.30 mm. (C) Day 26; LII is 1.26 mm. (D) Day 56; LII is 0.00 mm.
Figure 4Box plots showing differences in alignment rates (mm/week) between control and test (LAO) patients. The box plots were created using arch level data to provide a more accurate weighting of alignment rates over total treatment time. Arch level summaries and Wilcoxon rank-sum tests revealed that the combined LAO arches started at a higher average LII (8.39 mm versus 6.67 mm). There was no statistically significant difference between the two groups in terms of destination LII. Outliers (rates greater than 3 mm/week) were removed from the test group to make these figures more conservative. The test group's mean alignment rates were 0.99 compared to a control rate of 0.44, with a comparison group of 23 control arches and 111 treatment arches.
Multi-level mixed effects linear regression models predicting Little's Irregularity Index
| Model 1 | Model 2 | Model 3 | |
|---|---|---|---|
| Initial LII | 0.599* | 0.056 | 0.055 |
| Female | 0.241 | 0.257 | 0.317 |
| Age | 0.059** | 0.051** | 0.043 |
| Ethnicity | |||
| African | -0.798 | -0.585 | -0.609 |
| Asian | -0.191 | -0.167 | -0.279 |
| Other | -0.574 | -0.651 | -0.683 |
| Mandible | -0.092 | 0.007 | 0.009 |
| Test center | |||
| Test center 1 | -0.194 | 0.139 | -0.008 |
| Test center 2 | 0.025 | 0.349 | -0.082 |
| Test center 3 | -0.275 | -0.152 | -0.183 |
| Treatment time | -0.032* | -0.032** | -0.032** |
| LII (second) | 0.048* | 0.048* | |
| Treatment time (second) | 0.000*** | 0.000*** | |
| Treatment time × initial LII | -0.006**** | -0.006**** | |
| Device | -0.881*** | ||
| Constant | -0.749 | 0.591 | 1.584** |
| RI_Patient_Constant | 0.089 | -0.102 | -0.133 |
| RI_Arch_Constant | -0.550 | -0.351 | -0.358 |
| RI_Res_Constant | 0.483* | 0.357* | 0.355* |
| Chi square | 508.554 | 716.377 | 730.174 |
NS: 314 time intervals nested within 136 arches nested within 90 patients. * p < 0.001, ** p < 0.10, *** p < 0.05, **** p < 0.01.